Bosentan is also expected to reduce plasma concentrations of other statins that have significant metabolism by CYP3A4, such as lovastatin and atorvastatin.
<Bosentan, mechanism, statins>, <Bosentan, mechanism, lovastatin>, <Bosentan, mechanism, atorvastatin>